Search for: "Novartis Pharmaceuticals Corporation" Results 81 - 100 of 217
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Sep 2015, 2:20 pm by Tom Lamb
This September 2015 Drug Safety Alert Is Based Primarily On Reports Of Skin Cancer And Lymphoma Blood Cancer &nbsp (Posted by Tom Lamb at DrugInjuryWatch.com)   Health Canada recently conducted a review of safety information obtained from the drug company Novartis Pharmaceuticals Corporation, the manufacturer of Gilenya (fingolimod), about a potential link between the use of this multiple sclerosis (MS) drug and certain types of cancers and malignant tumors or… [read post]
17 Feb 2011, 1:59 pm by AALRR
  SmithKline Beecham Corporation (“Glaxo”) hired plaintiffs in 2003 to meet with physicians and encourage them to prescribe Glaxo pharmaceuticals. [read post]
30 Dec 2012, 3:30 am by Gene Quinn & Angel Krippner
On October 31, 2012, Acacia Research Corporation (Nasdaq:ACTG) announced that its subsidiaries... [read post]
18 Jun 2012, 1:38 pm
SmithKline Beecham Corporation that pharmaceutical sales representatives are not entitled to overtime pay under the Fair Labor Standards Act, as reported by the Wall Street Journal. [read post]
25 Nov 2011, 5:00 am by Bexis
Novartis Pharmaceuticals Corp., 2011 WL 5835414, slip op. [read post]
25 Aug 2010, 7:37 am by Levin & Perconti
The drug is manufactured by Finnish drugmaker Orion Corporation and is marked by Swiss-based Novartis Pharmaceuticals. [read post]
17 May 2010, 7:02 am by randal shaheen
A pop-up disclaimer for this third website -- you are “moving to an external website independently operated and not managed by the Novartis Pharmaceuticals Corporation” -- did nothing to dispel FDA’s belief that Novartis was responsible for its content. [read post]
3 Sep 2010, 9:43 am by Greenberg & Bederman
Some large corporations have a tendency to behave with ignorance when it comes to the internet. [read post]
22 Sep 2006, 12:17 pm
While the FDA has approved Novartis AG's Omnitrope hormone, there has not been a change in the stance taken by the FDA on generic biotechnology drugs. [read post]
2 Mar 2010, 6:28 am by John J. Cord
Up until now, online social networking has been treated mostly as a plaything for some pharmaceutical manufacturers. [read post]
3 May 2013, 6:33 pm by Swaraj Paul Barooah
One can hope that (while certainly corporations are people too), this '... for the people' government is trying to sort out their own (non-corporation) people's medical problems with the same vigour, for, at last check, they were still having plenty of issues with medical bills. [read post]
26 Mar 2011, 10:17 am
It is another in a spate of gender discrimination lawsuits filed recently against large corporations: last Monday a class action lawsuit was filed against Bayer HealthCare Pharmaceuticals and its parent, Bayer Corp., both U.S. units of Bayer AG, alleging the company has engaged in various discriminatory behaviors against its female employees. (1) The lawsuit, filed in U.S. [read post]
30 Aug 2009, 10:00 pm
Bivins (a citizen of Texas) sued Novartis Pharmaceuticals (a Delaware corporation with its principal place of business in New Jersey), Novartis Pharma GmbH (a German corporation), and Novartis AG (a Swiss corporation) in New Jersey state court. [read post]
21 Oct 2007, 12:55 pm
On March 30, 2007, the FDA requested that Novartis Pharmaceuticals Corporation ("Novartis"), the manufacturer of Zelnorm, voluntarily remove the drug from the market. [read post]
15 Oct 2008, 8:38 am
"In effect the Bush administration made the safety of Americans secondary to corporate profits. [read post]
6 Aug 2015, 2:08 pm by Tom Lamb
As regards the resulting August 2015 revision to the Gilenya Prescribing Information (also known as "package insert" and "drug label"), the FDA SUPPLEMENT APPROVAL letter (8/4/15) to Novartis Pharmaceuticals Corporation sets the stage: This supplemental application provides for addition of a new subsection to the Warnings and Precautions section of the prescribing information; the new subsection [5.3] describes the cases of progressive multifocal… [read post]
18 Mar 2014, 9:13 am by Saurabh Anand
  In addition, in July 2010, FDA issued an untitled letter to Novartis Pharmaceuticals Corporation relating to the “Facebook Share” widget on its Tasigna® product website. [read post]
2 Nov 2015, 2:05 pm by Michael Rosenblat
  (See, Blog post DOJ to Focus on Individual Accountability for Corporate Fraud.) [read post]
29 Mar 2012, 10:00 pm by Stephanie Figueroa
Prometheus. 3) Intellectual Property Watch: Novartis India Challenge Postponed To July – This post shares how the Indian Supreme Court today postponed hearing the high-profile case involving Swiss pharmaceutical producer Novartis’ challenge of India’s patent law until July. 4) Patents Post-Grant: AIA Changes to Greatly Increase Stays of District Court Actions – This post discusses the estoppel provisions of Post Grant Review and Inter… [read post]